Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sara Melisa Arciniegas Ruiz"'
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 14 (2022)
The protein kinase, GSK-3, participates in diverse biological processes and is now recognized a promising drug discovery target in treating multiple pathological conditions. Over the last decade, a range of newly developed GSK-3 inhibitors of diverse
Externí odkaz:
https://doaj.org/article/c86fe7868f0b41eabe4de6be5ca39431
Autor:
Ido Rippin, Netaly Khazanov, Shirley Ben Joseph, Tania Kudinov, Eva Berent, Sara Melisa Arciniegas Ruiz, Daniele Marciano, Laura Levy, Arie Gruzman, Hanoch Senderowitz, Hagit Eldar-Finkelman
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 22, p 8709 (2020)
The serine/threonine kinase, GSK-3, is a promising drug discovery target for treating multiple pathological disorders. Most GSK-3 inhibitors that were developed function as ATP competitive inhibitors, with typical limitations in specificity, safety a
Externí odkaz:
https://doaj.org/article/ff762e800dab45ae811f661ea1aa2c29
Autor:
Dinorah Vargas Estrada, Roberto Diaz Torres, Sara Melisa Arciniegas Ruiz, Raquel López Arellano, Sara del Carmen Caballero Chacón, María Josefa Bernad Bernad
Publikováno v:
Letters in Drug Design & Discovery. 16:948-960
Background: Alternatives routes of delivery for Insulin have been evaluated to improve treatment for Diabetes Mellitus. The oral route is the most convenient physiologically; it releases in a similar way to endogenous secretion. Flexible liposomes ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b057cafa559069268cb4489db1affe5
https://doi.org/10.2174/1570180816666190110112929
https://doi.org/10.2174/1570180816666190110112929
Publikováno v:
Cells. 11:1618
Over the last decade, there has been continuous progress in our understanding of the biology of the protein kinase GSK-3 [...]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f6a550c792dc5c2a06a5d5fac52e362
https://doi.org/10.3390/cells11101618
https://doi.org/10.3390/cells11101618
Autor:
Hanoch Senderowitz, Ido Rippin, Laura Levy, Tania Kudinov, Sara Melisa Arciniegas Ruiz, Daniele Marciano, Shirley Ben Joseph, Netaly Khazanov, Eva Berent, Arie Gruzman, Hagit Eldar-Finkelman
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 22
International Journal of Molecular Sciences, Vol 21, Iss 8709, p 8709 (2020)
Volume 21
Issue 22
International Journal of Molecular Sciences, Vol 21, Iss 8709, p 8709 (2020)
The serine/threonine kinase, GSK-3, is a promising drug discovery target for treating multiple pathological disorders. Most GSK-3 inhibitors that were developed function as ATP competitive inhibitors, with typical limitations in specificity, safety a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ef57b445cdb274e3b6d433dad64dd8a
Autor:
Lilia Gutiérrez Olvera, María Josefa Bernad Bernad, Sara del Carmen Caballero Chacón, Sara Melisa Arciniegas Ruiz, Dinorah Vargas Estrada
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 80
Doxycicline is used in dogs as treatment of several bacterial infections, mycoplasma, chlamydia and rickettsial diseases. However, it requires long treatments and several doses to be effective. The aim of this study was to determine the pharmacokinet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2568a79da2514fbecbe8b923ccd2d0b3
https://pubmed.ncbi.nlm.nih.gov/26393684
https://pubmed.ncbi.nlm.nih.gov/26393684